Archive: 15/04/2016

Study demonstrates benefits of existing treatment for hepatitis D patients

New research presented today shows that interferon alpha (IFNa) based therapies are effective in suppressing disease progression in a severe form of chronic viral hepatitis, Hepatitis delta.

Apr 15, 2016

Shorter treatment course potentially on the horizon for hep C patients

Data from a Phase 2 clinical trial show that an investigational injectable treatment known as RG-101 in combination with a four week course of oral direct-acting antiviral (DAA) treatment was well tolerated and resulted in ...

Apr 15, 2016

page 7 from 7

«
»